1. Home
  2. TCPC vs LAB Comparison

TCPC vs LAB Comparison

Compare TCPC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$3.25

Market Cap

280.2M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.78

Market Cap

326.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
LAB
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
280.2M
326.2M
IPO Year
2006
2008

Fundamental Metrics

Financial Performance
Metric
TCPC
LAB
Price
$3.25
$0.78
Analyst Decision
Sell
Hold
Analyst Count
2
1
Target Price
$3.50
$1.35
AVG Volume (30 Days)
654.0K
2.8M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
18.23%
N/A
EPS Growth
N/A
61.54
EPS
N/A
0.33
Revenue
N/A
$101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.63
P/E Ratio
N/A
$2.35
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$0.70
52 Week High
$7.41
$1.72

Technical Indicators

Market Signals
Indicator
TCPC
LAB
Relative Strength Index (RSI) 45.39 42.42
Support Level $3.10 $0.70
Resistance Level $3.54 $1.01
Average True Range (ATR) 0.10 0.07
MACD 0.02 -0.00
Stochastic Oscillator 51.92 9.64

Price Performance

Historical Comparison
TCPC
LAB

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: